diabetestalk.net

4 Things To Know About ACA Repeal And Diabetes

4 Things to Know About ACA Repeal and Diabetes

4 Things to Know About ACA Repeal and Diabetes


4 Things to Know About ACA Repeal and Diabetes
Posted on April 24, 2017 by American Diabetes Association
Update (5/31/17): On May 4th, the House of Representatives narrowly passed the American Health Care Act (AHCA). The AHCA has now moved to the Senate where Senators are currently considering potential changes to the legislation. If you havent already, please sign up to become an advocate and contact your Senators to urge them to protect health care for people with or at risk for diabetesand all Americans.
Over the past several months, all eyes have been on Congress and the White House, as debate has swirled around the repeal and replacement of the Patient Protection and Affordable Care Act (ACA). As advocates for the nearly 116 million Americans living with or at risk for diabetes, we at the American Diabetes Association are committed to protecting access to adequate and affordable health care for everyone no matter his or her health status, income, age or employment.
As you may have seen in the news, members of Congress returned home for their annual spring recess without passing legislation in the House of Representatives to repeal and replace the ACA. However, Congress returns to Washington on April 25 and a new vote on ACA repeal could happen within their first week in session.
If you or a loved one is affected by diabetes, heres what you should know:
Since December 2016, we have continuously urged Congress to not repeal the ACA without replacing it simultaneously with an alternative plan that does not result in a loss of coverage or benefits for people with, Continue reading

Rate this article
Total 1 ratings
‘Diabetes affects Indians at a younger age and progresses much faster’

‘Diabetes affects Indians at a younger age and progresses much faster’

India is among the countries which has the largest burden of diabetes in the world, says Dr. V. Mohan, the chairman and chief diabetologist at Dr. Mohan’s Diabetes Specialities Centre, a WHO Collaborating Centre for Noncommunicable Diseases Prevention and Control, in Chennai.
A Padma Shri recipient (2012) for his extensive contributions to the field of diabetes research, Dr. Mohan has recently been felicitated with the highest award for biomedical research in India -- Dr. B. R. Ambedkar Centenary Award -- by the Indian Council of Medical Research.
An alumnus of Madras Medical College, Dr. Mohan is also the president and director of Madras Diabetes Research Foundation, an ICMR Centre for advanced research on diabetes. He speaks to The Hindu about the disease, its implications, prevention and research in the area.
How has you extensive work in the field of diabetes helped the common man, especially with India having such a huge burden of the disease?
I have been working in the field of diabetes for nearly 40 years. I first started working on diabetes research as an undergraduate student helping my father, Prof. M.Viswanathan, who is considered the ‘Father of Diabetology’ in India.
Our initial studies were clinical, but they helped us understand the Asian Indian phenotype of diabetes better and laid the groundwork for my future research in this field. In my early years, I worked on a condition called “Fibro Calculus Pancreatic Diabetes”, which is a type of diabetes secondary to stones inside the pancreas. It is a rare form of diabetes, but my work helped to understan Continue reading

Starch-Based Vegan Diets And Diabetes: The Science-Backed Truth No One Wants You To Know

Starch-Based Vegan Diets And Diabetes: The Science-Backed Truth No One Wants You To Know


Top 3 Diabetes Myths, Busted: Fruit, Starchy Vegetables, and Blood Glucose
Almost 10 percent of Americans have diabetes and that number is growing. Unfortunately, the myths surrounding diabetes are as widespread as the disorder itself.
For the past 50 years, people diagnosed with all forms of diabetes have been advised to eat low-carb diets high in fat and protein, and to avoid eating high-carbohydrate foods like fruits, potatoes, squash, corn, beans , lentils , and whole grains .
Despite this popular opinion, more than 85 years of scientific research clearly demonstrates
that a low-fat, plant-based whole foods diet is the single most effective dietary approach for managing type 1 and type 2 diabetes. This means that a low-fat dietnot a low-carb diethas been shown across the board to minimize oral medication and insulin use, stabilize blood glucose, and dramatically reduce long-term disease risk in people with diabetes.
Myth #1: You Develop Type 2 Diabetes From Eating Too Much Sugar
Also see IS IT REALLY POSSIBLE TO EAT TOO MUCH FRUIT ON A VEGAN DIET?
Eating sweets is not a direct cause of type 2 diabetes. People develop type 2 diabetes over time by slowly developing a resistance to insulin, the hormone that escorts glucose out of your blood and into tissues like your muscle and liver. I like to think of type 2 diabetes as a very advanced form of insulin resistance in which glucose remains trapped in your blood because your body cannot use insulin properly. In this way, elevated blood glucose is a symptom of diabetes, and NOT the root cause.
The real cause of insu Continue reading

Why Resistance Training is Great for Diabetes Management

Why Resistance Training is Great for Diabetes Management

What if I told you that I have the magic formula for looking good, feeling amazing, and using less insulin (or other diabetes drugs)?!! Would you believe me?
Well I do have a magic formula!
But it’s not really magic, and you will have to work for it. The good news is that there is a readily available way of achieving those three things. It’s called resistance training.
What kind of magic is this?
From a diabetes perspective, resistance training really seems like magic, since it’s one of the most powerful ways to significantly improve insulin sensitivity.
Improved insulin sensitivity makes it easier to manage your diabetes (once you understand the new sensitivity patterns) and can significantly reduce the amount of diabetes drugs needed (goes for both T1D and T2D).
Think of your muscles as a lot of little “gas tanks” that can store glucose. Because glucose from your food is mainly absorbed by your muscle tissue, resistance training (which builds muscle mass) is particularly good at improving blood sugars after meals.
An added (and very welcome) benefit of resistance training is that you use a lot of energy (calories) to build and maintain your muscles, making it an excellent weight management tool. You don’t have to build bodybuilder-sized muscles to achieve this effect, or even the amount of muscle mass I have. Any improvement from where you are now will help.
Besides the (pretty awesome) diabetes management benefits, resistance training also has a large number of other health benefits, like improving bone density, strengthening your joints, and improving your m Continue reading

Glucose response holds key to better obesity and diabetes drugs

Glucose response holds key to better obesity and diabetes drugs

For the first time, South Australian researchers have recorded how human gut cells react to glucose, one of the key nutrients in our diet.
The study focuses on the secretion of a hormone called glucagon-like peptide 1 (or GLP-1) from the lining of the gut. When it is released after a meal, GLP-1 triggers insulin secretion from the pancreas and signals fullness, to limit further food intake.
As a result, this hormone has been the focus of significant new drug development for type 2 diabetes and obesity in the past decade.
“But while we knew that GLP-1 was important in diabetes and obesity treatment, we still knew little about how the release of this hormone was controlled in humans,” says research leader Professor Damien Keating, from Flinders University and the South Australian Health and Medical Research Institute (SAHMRI).
“We have now recorded how the arrival of glucose in the upper intestine triggers the release of this important hormone, which has been a chief therapeutic target for a number of diabetes and new anti-obesity drugs,” Professor Keating says.
“By learning more about the gut’s mechanism to process glucose and produce this hormone, we can begin to develop potential new therapies which may be much more targeted and effective.”
With obesity and Type 2 (acquired) diabetes on the rise, these therapies will be important in increasing public health and wellbeing, and in reducing the future cost burden of these conditions to the community.
Drugs that mimic GLP-1, or increase its levels in blood, are now used successfully for the treatment of people wi Continue reading

No more pages to load

Popular Articles

Related Articles